BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35918741)

  • 1. Beyond COVID-19 and lessons learned in the United States.
    Gammon R; Katz LM; Strauss D; Rowe K; Menitove J; Benjamin RJ; Goel R; Borge D; Reichenberg S; Smith R
    Transfus Med; 2023 Feb; 33(1):6-15. PubMed ID: 35918741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic.
    Wendel S; Land K; Devine DV; Daly J; Bazin R; Tiberghien P; Lee CK; Arora S; Patidar GK; Khillan K; Smid WM; Vrielink H; Oreh A; Al-Riyami AZ; Hindawi S; Vermeulen M; Louw V; Burnouf T; Bloch EM; Goel R; Townsend M; So-Osman C
    Vox Sang; 2021 Sep; 116(8):872-879. PubMed ID: 33772791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening donors for COVID-19 convalescent plasma.
    Wang HE; Ostrosky-Zeichner L; Katz J; Wanger A; Bai Y; Sridhar S; Patel B
    Transfusion; 2021 Apr; 61(4):1047-1052. PubMed ID: 33368395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of a pilot program for COVID-19 convalescent plasma collection in Wuhan, China.
    Li L; Yang R; Wang J; Lv Q; Ren M; Zhao L; Chen H; Xu H; Xie S; Xie J; Lin H; Li W; Fang P; Gong L; Wang L; Wu Y; Liu Z
    Transfusion; 2020 Aug; 60(8):1773-1777. PubMed ID: 32491199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparedness and activities of the anti-SARS-CoV-2 convalescent plasma bank in the Veneto region (Italy): An organizational model for future emergencies.
    De Silvestro G; Gandini G; Fiorin F; Marson P; Barbone E; Frigato A; Gessoni G; Veronesi A; Pacenti M; Castelli M; Rinaldi M; Rizzi M; Stefani F; Roveroni G
    Transfus Apher Sci; 2021 Aug; 60(4):103154. PubMed ID: 33994107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoting access to COVID-19 convalescent plasma in low- and middle-income countries.
    Bloch EM; Goel R; Montemayor C; Cohn C; Tobian AAR
    Transfus Apher Sci; 2021 Feb; 60(1):102957. PubMed ID: 32972861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deterrents in recruitment of COVID-19 convalescent plasma donors: Experience from a hospital-based blood centre in India.
    Dhiman Y; Coshic P; Pandey HC; Khatiwada B; Singh J; Mehta V; Gupta S
    Transfus Med; 2021 Jun; 31(3):149-154. PubMed ID: 33749020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How we secured a COVID-19 convalescent plasma procurement scheme in Japan.
    Terada M; Kutsuna S; Togano T; Saito S; Kinoshita N; Shimanishi Y; Suzuki T; Miyazato Y; Inada M; Nakamoto T; Nomoto H; Ide S; Sato M; Maeda K; Matsunaga A; Satake M; Matsubayashi K; Tsuno H; Kojima M; Kuramistu M; Tezuka K; Ikebe E; Okuma K; Hamaguchi I; Shiratori K; Sato M; Kawakami Y; Inaba K; Igarashi S; Yamauchi R; Matsumura M; Ishimaru K; Zhang B; Kuge C; Ishihara M; Gouda M; Tanaka K; Ishizaka Y; Ohmagari N
    Transfusion; 2021 Jul; 61(7):1998-2007. PubMed ID: 34096059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory challenges of convalescent plasma collection during the evolving stages of COVID-19 pandemic in the United States.
    Hassan S; West KA; Conry-Cantilena K; De Giorgi V
    Transfusion; 2022 Feb; 62(2):483-492. PubMed ID: 34778974
    [No Abstract]   [Full Text] [Related]  

  • 10. Challenges in Establishing a Coronavirus Disease 2019 (COVID-19) Convalescent Plasma Donation Program in a Multicultural Environment.
    Algora M; Mehmood T; Madison DL; AlAmeri J; Abuzakouk M; Tagamtam M; Acena L; Totaan G; Grabski G; Oumeziane N; Rajani P; Taylor L; Guzman J; AbdelWareth LO
    Arch Pathol Lab Med; 2021 Dec; 145(12):1479-1484. PubMed ID: 34407176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital-Based Donor Recruitment and Predonation Serologic Testing for COVID-19 Convalescent Plasma.
    Balcerek J; Trejo E; Levine K; Couey P; Kornberg ZV; Rogine C; Young C; Li PJ; Shy BR; Taylor JE; Bakhtary S; Friedlander T; Lynch KL; Bern C; Esensten JH
    Am J Clin Pathol; 2021 Mar; 155(4):515-521. PubMed ID: 33399201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid development of a de novo convalescent plasma program in response to a global pandemic: A large southeastern U.S. blood center's experience.
    Reik R; Gammon RR; Carol N; Smith J; Grable M; Forbes S; Wu Y; Reed L; Rogers M; Prichard A; Paul S; Scholl G
    J Clin Apher; 2021 Aug; 36(4):533-546. PubMed ID: 33648025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convalescent plasma and COVID-19: Time for a second-second look?
    Joyner MJ; Carter RE; Fairweather D; Wright RS
    Transfus Med; 2023 Feb; 33(1):16-20. PubMed ID: 36089562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of coronavirus disease 19 convalescent plasma donors and donations in the New York metropolitan area.
    Jain S; Garg K; Tran SM; Rask IL; Tarczon M; Nandi V; Kessler DA; Strauss D; Sachais BS; Yazdanbakhsh K; Rehmani S; Luchsinger L; Shi PA
    Transfusion; 2021 Aug; 61(8):2374-2383. PubMed ID: 33904609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemic.
    Al-Riyami AZ; Burnouf T; Wood EM; Devine DV; Oreh A; Apelseth TO; Goel R; Bloch EM; van Den Berg K; Getshen M; Louw V; Ang AL; Lee CK; Rahimi-Levene N; Stramer SL; Vassallo R; Schulze TJ; Patidar GK; Pandey HC; Dubey R; Badawi M; Hindawi S; Meshi A; Matsushita T; Sorrentino E; Grubovic Rastvorceva RM; Bazin R; Vermeulen M; Nahirniak S; Tsang HC; Vrielink H; Triyono T; Addas-Carvalho M; Hećimović A; Torres OW; Mutindu SM; Bengtsson J; Dominguez D; Sayedahmed A; Hanisa Musa R; Gautam B; Herczenik E; So-Osman C;
    Vox Sang; 2022 Jun; 117(6):822-830. PubMed ID: 35262978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2/COVID-19 pandemic: first wave, impact, response and lessons learnt in a fully integrated Regional Blood and Tissue Bank. A narrative report.
    Garcia-Lopez J; Delgadillo J; Vilarrodona A; Querol S; Ovejo J; Coll R; Millan A; Madrigal A; Soria G; Vidal F; Vives J; Herrero MJ; Lopez I; Sauleda S; Contreras E; Grifols JR; Guasch R; Tahull E; Puig L; Masip A; Argelagués E; Muñiz-Diaz E
    Blood Transfus; 2021 Mar; 19(2):158-167. PubMed ID: 33539280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 neutralizing capacity among blood donors without prior COVID-19 symptomatic history vs. blood donors with prior COVID-19 symptomatic history: A comparative study.
    Ravula U; Chunchu SR; Mooli S; Naik R; Sarangapati PRR
    Transfus Clin Biol; 2022 May; 29(2):107-111. PubMed ID: 35167958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors.
    Leon J; Merrill AE; Rogers K; Kurt J; Dempewolf S; Ehlers A; Jackson JB; Knudson CM
    Transfus Apher Sci; 2022 Apr; 61(2):103326. PubMed ID: 34862140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 convalescent plasma donor recruitment: beware the Faustian bargains.
    Gniadek TJ; Donnersberger D
    Transfusion; 2020 Jul; 60(7):1643-1644. PubMed ID: 32428966
    [No Abstract]   [Full Text] [Related]  

  • 20. The demographic and serological characteristics of COVID-19 convalescent plasma donors: Identification of basic criteria for optimal donor selection.
    Fazeli A; Sharifi S; Mohammadi S; Bahraini M; Arabkhazaeli A; Jelveh N; Eshghi P
    Transfus Apher Sci; 2022 Apr; 61(2):103302. PubMed ID: 34774440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.